JAMMU, Nov 23: American Oncology Institute (AOI), one of South Asia’s leading chains of cancer hospitals marked its journey of 3 years with 7000+ cancer screenings in Jammu & Kashmir.
As per Union Health Ministry’s figures, J&K has reported an estimated 39041 cancer cases, of which 12675 were recorded in 2019, 13012 in 2020 and 13354 in 2021. Stomach cancer is the most reported cancer followed by colorectal cancer and lung cancer among males. For females, colorectal cancer, breast cancer and stomach cancer were the most frequently reported cancers.
With the latest technology and state-of-the-art facility, AOI regularly organizes cancer screening camps and offers precision cancer care solutions for pre-cancer and cancer patients in J&K region. AOI is one of the fastest growing health care services.
Speaking on the occasion, Dr Neeraj Bishnoi, Regional COO AOI, said, “The successfully completion of 3 years of AOI is a mark of dedication and pride in providing precision cancer care for the people in the J&K. By seizing the benefits of technology, AOI has brought healthcare services closer to the patients. Continuing our commitment to offer best-in-class clinical expertise, technological superiority, and service excellence, we constantly enhanced operational capabilities at AOI.”
Revolutionising cancer treatment with first and only PET-CT scan and much more, AOI continues to achieve higher milestones. American Oncology Institute is empanelled with Ayushman Bharat Scheme and all leading TPAs to offer best cancer care services to the patients.
Improving the diagnostic and treatment care facility, AOI further offers free tests and services like Mammography, Bone Densitometry, Pap Smear, PSA, and other lab tests along with free Oncology, Gynaecology, and general consultation at the cancer screening camps.
Speaking on the occasion, Vikrant Thakur, Facility Director AOI Jammu, said, “It is a momentous occasion for us today as AOI Jammu celebrates its 3rd anniversary since its inception in 2019. The patient is the focus of all our initiatives to deliver cutting-edge treatments and bring advances in medical technology.”